Inovalon Holdings Inc

Inovalon — Q2 2020 Earnings Presentation

33 slides from Inovalon's earnings presentation, Jul 29, 2020

  1. Slide 1: Q2 2020 Earnings Supplement

    Q2 2020 Earnings Supplement July 29, 2020

  2. Slide 2: Cautionary Note Regarding Forward-Looking Statement

    Cautionary Note Regarding Forward-Looking Statement Certain statements contained in this presentation constitute forward-looking statements within the meaning of, and are intended to be covered by the safe harbor provisions of, Section 27A of the Securities Act of 1933, as amended, and Section 21E o

  3. Slide 3: Contents

    Contents 1 Overview 2 2020 Q2 & TTM Financial Results This presentation serves as a supplement to the Inovalon announcement on July 29, 2020 pertaining to second quarter (Q2) of 3 2020 Financial Guidance 2020 results and guidance. 4 Appendix 1: Reconciliations INOV Q2 2020 Earnings Supplement (7.29.

  4. Slide 4: The Inovalon ONE Platform

    Payers Pharmacies Pharmaceuticals Devices Diagnostics The Inovalon ONE® Platform Inovalon is a leading provider of cloud- based platforms empowering data-driven healthcare. Inovalon provides cloud-based, real-time Massive Advanced Intervention Data connectivity, analytics, intervention, and Data Ass

  5. Slide 5: Empowering Data-Driven Healthcare In Scale

    Empowering Data-Driven Healthcare In Scale The reach of Inovalon’s platform has grown to touch the vast majority of the United States, able to empower the market’s largest data-driven healthcare initiatives. 100s Health Plans, Providers, Life Sciences, Pharmacy, and Diagnostics Organizations 319M+ P

  6. Slide 6: Executing on Strategy

    Executing on Strategy Inovalon’s three strategy guideposts are lead in innovation, become the enablement layer, and land and expand efficiently. Inovalon Lead in Innovation Become the Enablement Layer Land and Expand Efficiently Bring to market the industry’s most Leverage the resulting capabilities

  7. Slide 7: Cloud-Based Platform Approach

    Cloud-Based Platform Approach Inovalon provides its solutions to the marketplace through the Inovalon ONE® Platform: an integrated, real-time cloud native platform which brings together the capabilities of extensive healthcare ecosystem connectivity, massive scale datasets, advanced analytics, and d

  8. Slide 8: Massive Real-World Data Assets

    Massive Real-World Data Assets 56 MORE2 REGISTRY® DATASET GROWTH 54 52 Patient Count Medical Event Count 50 Inovalon leverages massive datasets to 48 deliver differentiated capabilities to its clients. 46 44 These datasets are expanding rapidly. As of the 42 40 2 ® end of Q2 2020, the MORE Registry

  9. Slide 9: Benefits of Inovalon's Massive Primary-Source Dataset

    Benefits of Inovalon’s Massive Primary-Source Dataset The significant size, extensive breadth of data types, historical duration, recency timeliness, and fully linkable primary- sourced nature of Inovalon’s datasets provides a uniquely rich, longitudinally matched real-world dataset able to empower

  10. Slide 10: Highly Differentiated Within the Market

    Highly Differentiated Within the Market A leader in providing cloud-based tools to support data-driven healthcare, Inovalon empowers clients to achieve their clinical quality and financial goals by bringing highly differentiated capabilities to bear – unavailable from any other platform provider. Ma

  11. Slide 11: Consumer Health Gateway

    Consumer Health Gateway™ On May 21, 2020 Inovalon launched the Consumer Health Gateway™, a cloud-based Fast Healthcare Interoperability Resources (FHIR®)- enabled Module of the Inovalon ONE® Platform that enables health plans with Medicare Advantage, Commercial ACA and Medicaid/CHIP insurance produc

  12. Slide 12: InfectionWatch

    InfectionWatch™ On May 27, 2020 Inovalon launched InfectionWatch™ for the provider marketplace, a cloud-based infection control and antibiotic stewardship Module within the Inovalon ONE® Platform. Timely infection outbreak management requires real-time actionable data that can empower skilled nursin

  13. Slide 13: Contents

    Contents 1 Overview 2 2020 Q2 & TTM Financial Results This presentation serves as a supplement to the Inovalon announcement on July 29, 2020 pertaining to second quarter (Q2) of 3 2020 Financial Guidance 2020 results and guidance. 4 Appendix 1: Reconciliations INOV Q2 2020 Earnings Supplement (7.29.

  14. Slide 14: Q2 2020 Financial Highlights

    Subscription-Based Quarterly New Sales Q2 2020 Platform Revenue of Annual Contract Value (ACV) to a Financial $142.1M Record Representing $75.7M Highlights Strong Growth of An increase of During Q2 2020 Inovalon’s revenue grew 13% 38% 3% year-over-year to $162.2 million, and year-over-year year-over

  15. Slide 15: Continued Solid Sales Performance

    Continued Solid Sales Performance The Company continued to see strong demand through the second quarter with new sales Annual Contract Value1 (ACV) achieving a new record $75.7 million, with platform new sales, excluding Services, ACV totaling $57.5 million, reflecting a year-over-year increase of 3

  16. Slide 16: Continued Growth Momentum

    Continued Growth Momentum The strong market demand for Inovalon’s cloud-based platforms and data-empowered capabilities, together with the growing sophistication of sales and the increasing operating leverage of the Company’s technologies and business model, is continuing to drive both meaningful mo

  17. Slide 17: Continued Salesforce Focus

    Continued Salesforce Focus During the second quarter of 2020, Inovalon’s sales force focused on adapting to remote/virtual selling techniques, honing of newly launched product messaging, and the ongoing refinement of the Company’s overall go-to-market process. The ongoing investment continues to dem

  18. Slide 18: Continued Headcount Efficiency Improvements

    Continued Headcount Efficiency Improvements The Company’s transition to higher-valued cloud-based offerings leveraging increased connectivity, software automation, SaaS- based, and subscription-based offerings continues to witness a substantial corresponding decrease in headcount while concurrently

  19. Slide 19: Contents

    Contents 1 Overview 2 2020 Q2 & TTM Financial Results This presentation serves as a supplement to the Inovalon announcement on July 29, 2020 pertaining to second quarter (Q2) of 3 2020 Financial Guidance 2020 results and guidance. 4 Appendix 1: Reconciliations INOV Q2 2020 Earnings Supplement (7.29.

  20. Slide 20: Strong Subscription-Based Platform Adoption

    Strong Subscription-Based Platform Adoption The graphic below illustrates the revenue offering mix, which includes the Company’s revised 2020 guidance range as updated on July 29, 2020. $675- $698 $642.4 ~10% 2016 – 2020G 11% ~5% 26% Subscription-Based CAGR $527.7 6% $449.4 11% $427.6 9% 12% 15% 19%

  21. Slide 21: Expected Quarterly Revenue Cadence

    Expected Quarterly Revenue Cadence The following illustration outlines the Company’s current 2020 quarterly revenue cadence expectation as impacted by the COVID-19 crisis, which reflects 5% to 9% year-over-year organic revenue growth as updated on July 29, 2020. YoY Organic Quarterly Revenue Growth

  22. Slide 22: Adjusted EBITDA

    Adjusted EBITDA The graphic below illustrates the Company’s 2020 Adjusted EBITDA and Adjusted EBITDA margin guidance as updated on July 29, 2020. $226 - $236 $211 2016 – 2020G 23% CAGR $152 $109 $100 33% 34% 29% 23% 24% 2016 2017 2018 2019 2020G % of Revenue Note: CAGR calculations undertaken to the

  23. Slide 23: Cash Flow From Operations

    Cash Flow From Operations The graphic below illustrates the Company’s 2020 Cash Flow from Operations guidance as updated on July 29, 2020. 2 $160 - $175 2016 – 2020G 16% CAGR $106 $1041 $98 $93 $90 24% 22% 22% 17% 17% 2016 2017 2018 2019 2020G % of Revenue Note: CAGR calculations undertaken to the m

  24. Slide 24: CAPEX Returning Towards Historical Levels

    CAPEX Returning Towards Historical Levels During the period Q3 2016 through Q1 2018, the Company elected to invest more than $40M into incremental development towards the launch of the Inovalon ONE® Platform. The period of this disproportional investment is now complete and is increasingly being har

  25. Slide 25: Covenant-Lite Debt Leverage

    Covenant-Lite Debt Leverage On April 2, 2018, the Company put in place a $980M seven-year term debt facility and $100M five-year revolving debt facility, collectively the credit facility. Proceeds were used, among other things, to pay off all of the Company’s existing debt obligations of $225M as we

  26. Slide 26: Full Year 2020 Financial Guidance

    Full Year 2020 Financial Guidance In the setting of the substantive contract wins achieved in the second quarter of 2020 and the expectation of additional substantive wins during the second half of 2020, the Company raised the low end of its revenue range and increased Adjusted EBITDA and non-GAAP d

  27. Slide 27: Q3 2020 Financial Guidance

    Q3 2020 Financial Guidance Inovalon is providing Q3 2020 guidance as provided below, indicating 5% to 11% year-over-year organic revenue growth. Q3 2020 Financial Financial Metric Guidance Revenue $175 million to $185 million Net Income 1 $7 million to $8 million Non-GAAP net income1 $25 million to

  28. Slide 28: Contents

    Contents 1 Overview 2 2020 Q2 & TTM Financial Results This presentation serves as a supplement to the Inovalon announcement on July 29, 2020 pertaining to second quarter (Q2) of 3 2020 Financial Guidance 2020 results and guidance. 4 Appendix 1: Reconciliations INOV Q2 2020 Earnings Supplement (7.29.

  29. Slide 29: Reconciliation of Forward-Looking Guidance Adjusted EBITDA

    Reconciliation of Forward-Looking Guidance Adjusted EBITDA Inovalon defines Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA) as net income or loss calculated in accordance with GAAP, adjusted for the impact of depreciation and amortization, other expense, net

  30. Slide 30: Reconciliation of Forward-Looking Guidance Non-GAAP Net Income

    Reconciliation of Forward-Looking Guidance Non-GAAP Net Income Inovalon defines Non-GAAP net income as net income or loss calculated in accordance with GAAP, adjusted to exclude tax-affected stock-based compensation expense, acquisition costs, restructuring expense, amortization of acquired intangib

  31. Slide 31: Definitions

    Definitions 1. Annual Recurring Revenue is defined as subscription-based revenue from existing clients plus outstanding intra-year renewals valued at an amount agreed upon in principal. 2. Annual Revenue Retention is defined as the percentage of revenue from engagements with existing clients in the

  32. Slide 32: ACV, TCV and Bookings

    ACV, TCV and Bookings Inovalon’s sales have significantly expanded and accelerated, supporting strong growth going forward. The Company started reporting its sales performance in 2018 by providing new sales Annual Contract Value (ACV) data, a metric reflecting the sum of the first 12 months of reven

  33. Slide 33: Healthcare Empowered

    Healthcare Empowered® © 2020 by Inovalon. All rights reserved.

Inovalon Holdings — Q2 2020 Earnings Presentation on 6ix